Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
Evanthia Mergia, … , Michael Russwurm, Doris Koesling
Evanthia Mergia, … , Michael Russwurm, Doris Koesling
Published June 1, 2006
Citation Information: J Clin Invest. 2006;116(6):1731-1737. https://doi.org/10.1172/JCI27657.
View: Text | PDF
Research Article Vascular biology

Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system

  • Text
  • PDF
Abstract

In the vascular system, the receptor for the signaling molecule NO, guanylyl cyclase (GC), mediates smooth muscle relaxation and inhibition of platelet aggregation by increasing intracellular cyclic GMP (cGMP) concentration. The heterodimeric GC exists in 2 isoforms (α1-GC, α2-GC) with indistinguishable regulatory properties. Here, we used mice deficient in either α1- or α2-GC to dissect their biological functions. In platelets, α1-GC, the only isoform present, was responsible for NO-induced inhibition of aggregation. In aortic tissue, α1-GC, as the major isoform (94%), mediated vasodilation. Unexpectedly, α2-GC, representing only 6% of the total GC content in WT, also completely relaxed α1-deficient vessels albeit higher NO concentrations were needed. The functional impact of the low cGMP levels produced by α2-GC in vivo was underlined by pronounced blood pressure increases upon NO synthase inhibition. As a fractional amount of GC was sufficient to mediate vasorelaxation at higher NO concentrations, we conclude that the majority of NO-sensitive GC is not required for cGMP-forming activity but as NO receptor reserve to increase sensitivity toward the labile messenger NO in vivo.

Authors

Evanthia Mergia, Andreas Friebe, Oliver Dangel, Michael Russwurm, Doris Koesling

×

Figure 4

Vasorelaxing properties of α-deficient aortic rings.

Options: View larger image (or click on image) Download as PowerPoint
Vasorelaxing properties of α-deficient aortic rings.
Functional response...
Functional responses of aortic rings were determined as described in Methods. (A) Cumulative concentration-response curves of GSNO-induced relaxation of α1- and α2-deficient rings (n = 3 in each group). (B) GSNO-induced relaxation of WT and α1-deficient rings in the presence of the inhibitor of NO-sensitive GC, ODQ. Shown are the original recordings using 10 μM GSNO and 20 μM ODQ. ANP (10 nM) was added to confirm integrity of the rings. (C) NO-stimulated GC activities (100 μM DEA-NO) determined in aortic homogenates (n = 5 per genotype). (D) Carbachol-induced relaxation of WT and α-deficient aortic rings in the absence or presence of ODQ (n = 3–8 per genotype). Experiments used 30 μM carbachol and 20 μM ODQ.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts